Drug Trial Radar · NCT00547287
Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations
Last checked: Nov 19, 2026Latest source record: Oct 22, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,760
Actual
Start
Nov 2002
Primary completion
Not stated
Study completion May 2004
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- ICOS Corporation
- First posted
- Oct 22, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to determine if men from around the world prefer sildenafil to tadalafil.
Conditions
- Impotence
Interventions
tadalafilDrug
20 mg tadalafil as needed by mouth no more than once a day for a 4 week initiation period and a 4 weeks treatment period.
sildenafilDrug
Current dosage of sildenafil is continued for 4 weeks (no more than once a day) of treatment assessment then the wash-out period will begin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patient choice of treatment (either sildenafil or tadalafil) for use in the extension phaseTime frame: 14 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.